COGT Cogent Biosciences, Inc.

Fundamentals / CIK 0001622229 / USD

Cogent Biosciences, Inc. reported $832.1M in total assets and a net loss of $407.7M through December 31, 2025 from SEC EDGAR filings.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open COGT in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

9 fiscal years (2017 to 2025), reported in USD.

$56.91M$28.46M$0-$309.5MFY 2017 Revenue: $8.36MFY 2017 Net Income: -$25.49M2017FY 2018 Revenue: $9.73MFY 2018 Net Income: -$34.53M2018FY 2019 Revenue: $22.50MFY 2019 Net Income: -$31.83M2019FY 2020 Revenue: $7.87MFY 2020 Net Income: -$74.81M2020FY 2021 Net Income: -$72.27M2021FY 2022 Net Income: -$140.2M2022FY 2023 Net Income: -$192.4M2023FY 2024 Net Income: -$255.9M2024FY 2025 Net Income: -$328.9M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Revenue -- -- -- -- -- $7.87M $22.50M $9.73M $8.36M
Research & Development $269.8M $232.7M $173.8M $121.6M $55.91M $25.74M $43.71M $38.28M $29.83M
Operating Income -$333.4M -$275.9M -$208.1M -$147.8M -$75.55M -$82.20M -$32.18M -$36.01M -$26.15M
EBITDA -$330.8M -$273.4M -$205.8M -$147.0M -$75.40M -$81.48M -$30.89M -$34.68M -$24.98M
Interest Income $14.69M $18.09M $13.08M $3.99M $467K $144K $267K $1.15M $386K
Interest Expense $3.06M -- -- -- -- -- -- -- --
Income Tax Expense $0 -- -- -- -- -- -- -- --
Net Income -$328.9M -$255.9M -$192.4M -$140.2M -$72.27M -$74.81M -$31.83M -$34.53M -$25.49M
Basic EPS -$2.16 -$1.94 -$1.94 -$1.73 -$1.87 -$16.17 -$4.18 -$1.39 -$2.51
Diluted EPS -$2.16 -$1.94 -$1.94 -$1.73 -$1.87 -$16.17 -$4.18 -$1.39 -$2.51
Basic Shares Outstanding 128.9M 103.9M 79.7M 58.7M 38.7M 11.1M 7.6M 24.9M 10.2M
Diluted Shares Outstanding 128.9M 103.9M 79.7M 58.7M 38.7M 11.1M 7.6M 24.9M 10.2M

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Research & Development $75.10M $70.81M $75.36M $75.56M $68.99M $62.20M $63.03M $62.05M
Operating Income -$117.2M -$102.6M -$103.6M -$99.49M -$83.36M -$75.58M -$74.93M -$73.73M
EBITDA -$116.6M -$101.9M -$103.0M -$98.83M -$82.71M -$74.93M -$74.29M -$73.06M
Interest Income $7.05M $7.46M $7.61M $5.48M $3.89M $2.37M $2.95M $3.86M
Interest Expense $1.24M $1.22M $1.21M -- $1.46M $314K -- --
Net Income -$111.4M -$96.41M -$97.35M -$102.5M -$80.93M -$73.53M -$71.99M -$67.93M
Basic EPS -$0.59 -$0.52 -$0.53 -- -$0.50 -$0.53 -$0.52 --
Diluted EPS -$0.59 -$0.52 -$0.53 -- -$0.50 -$0.53 -$0.52 --
Basic Shares Outstanding 173.1M 171.0M 162.2M -- 137.6M 114.5M 113.3M --
Diluted Shares Outstanding 173.1M 171.0M 162.2M -- 137.6M 114.5M 113.3M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $312.0M $98.17M $53.23M $139.9M $219.7M $242.2M $37.42M $55.67M $28.27M
Short-Term Investments $588.8M $188.9M $212.5M $119.4M $0 -- -- -- $12.69M
Cash & Short-Term Investments $900.8M $287.1M $265.7M $259.3M $219.7M $242.2M $37.42M $55.67M $40.96M
Accounts Receivable, Net -- -- -- -- -- -- $2.00M $1.67M $830K
Total Current Assets $910.4M $296.5M $270.8M $265.0M $222.6M $244.9M $40.59M $81.00M $42.38M
Property, Plant & Equipment, Net $5.46M $6.47M $8.34M $7.78M $1.71M $134K $1.86M $3.25M $4.11M
Long-Term Investments -- -- $7.46M $0 -- -- -- -- --
Other Non-Current Assets $3.30M $4.86M $4.86M $4.75M $3.73M -- $427K $419K --
Total Non-Current Assets $27.25M $31.43M $42.67M $35.84M $9.46M $6.00M $8.83M $4.92M $6.74M
Total Assets $937.6M $327.9M $313.4M $300.8M $232.1M $250.9M $49.42M $85.93M $49.12M
Accounts Payable $9.50M $12.01M $10.65M $5.84M $3.48M $732K $3.18M $1.52M $1.35M
Deferred Revenue (Current) -- -- -- -- -- -- $1.31M $17.95M $6.89M
Total Current Liabilities $63.95M $55.71M $38.17M $26.85M $17.08M $13.09M $13.25M $24.95M $11.19M
Long-Term Debt $222.9M $0 -- -- -- -- -- -- --
Deferred Revenue (Non-Current) -- -- -- -- -- -- -- -- $8.71M
Other Non-Current Liabilities $33K $0 -- -- -- -- -- -- --
Total Non-Current Liabilities $237.3M $15.90M $17.47M $18.23M $831K $3.15M $4.41M $748K $9.62M
Total Liabilities $301.2M $71.61M $55.63M $45.08M $17.91M $16.25M $17.66M $25.69M $20.81M
Total Debt (incl. Leases) $238.8M $17.47M $18.85M $19.65M $3.15M $5.21M $6.03M -- --
Common Stock $161K $110K $86K $70K $44K $32K $8.0K $30K $10K
Retained Earnings -$1.19B -$859.5M -$603.6M -$411.2M -$271.0M -$198.7M -$123.9M -$92.06M -$51.34M
Accumulated Other Comp. Income $355K $447K $246K -$104K -- -- -- -$12K -$16K
Total Stockholders' Equity $636.4M $256.3M $257.8M $255.7M $214.2M $234.7M $31.76M $60.23M -$48.85M
Total Equity $636.4M $256.3M $257.8M $255.7M $214.2M $234.7M $31.76M $60.23M -$48.85M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $217.5M $181.2M $241.2M $312.0M $125.3M $127.6M $126.0M $98.17M
Short-Term Investments $573.7M $611.1M $625.2M $588.8M $265.6M $110.2M $119.7M $188.9M
Cash & Short-Term Investments $791.1M $792.3M $866.4M $900.8M $390.9M $237.8M $245.7M $287.1M
Total Current Assets $803.6M $804.8M $877.8M $910.4M $397.2M $245.0M $252.9M $296.5M
Property, Plant & Equipment, Net $4.31M $4.78M $5.30M $5.46M $5.27M $5.85M $6.45M $6.47M
Other Non-Current Assets $1.91M $1.94M $1.94M $3.30M $4.49M $4.86M $4.86M $4.86M
Total Non-Current Assets $28.56M $29.73M $25.20M $27.25M $28.69M $29.81M $30.91M $31.43M
Total Assets $832.1M $834.5M $903.0M $937.6M $425.9M $274.8M $283.8M $327.9M
Accounts Payable $5.94M $7.49M $13.74M $9.50M $16.03M $16.62M $14.15M $12.01M
Total Current Liabilities $73.12M $59.30M $57.98M $63.95M $62.25M $58.42M $49.32M $55.71M
Long-Term Debt $223.7M $223.5M $223.2M $222.9M $44.25M $43.95M -- $0
Other Non-Current Liabilities $123K $90K $62K $33K $2.37M $2.36M $5.0K $0
Total Non-Current Liabilities $242.8M $242.9M $237.3M $237.3M $61.22M $61.36M $15.48M $15.90M
Total Liabilities $315.9M $302.2M $295.3M $301.2M $123.5M $119.8M $64.80M $71.61M
Total Debt (incl. Leases) $244.2M $244.3M $238.7M $238.8M $60.56M $60.66M $17.09M $17.47M
Common Stock $174K $171K $171K $161K $141K $114K $114K $110K
Retained Earnings -$1.49B -$1.38B -$1.29B -$1.19B -$1.09B -$1.00B -$931.5M -$859.5M
Accumulated Other Comp. Income -$717K -$770K -$415K $355K $208K $13K $164K $447K
Total Stockholders' Equity $516.3M $532.4M $607.7M $636.4M $302.5M $155.0M $219.0M $256.3M
Total Equity $516.3M $532.4M $607.7M $636.4M $302.5M $155.0M $219.0M $256.3M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$328.9M -$255.9M -$192.4M -$140.2M -$72.27M -$74.81M -$31.83M -$34.53M -$25.49M
Depreciation & Amortization $2.60M $2.50M $2.30M $800K $147K $720K $1.29M $1.32M $1.17M
Stock-Based Compensation $46.08M $39.74M $30.62M $18.37M $11.69M $6.02M $3.24M $3.09M $1.34M
Change in Receivables -- -- -- -- -- $2.00M -$332K -$838K $98K
Change in Payables -$2.51M $1.36M $4.81M $2.36M $2.75M -$2.45M $1.66M $367K -$31K
Operating Cash Flow -$264.4M -$207.8M -$153.6M -$118.6M -$58.76M -$35.85M -$41.51M -$32.49M -$25.84M
Capital Expenditure -$1.55M -$573K -$2.80M -$6.86M -$1.72M -- -$33K -$549K -$912K
Free Cash Flow -$266.0M -$208.4M -$156.4M -$125.5M -$60.48M -- -$41.55M -$33.04M -$26.75M
Purchases of Investments -$687.2M -$255.6M -$348.8M -$177.9M $0 -- -- -$47.68M -$6.50M
Investing Cash Flow -$399.5M $38.28M -$97.82M -$124.7M -$1.72M $8.42M $23.16M -$10.53M $13.59M
Common Stock Issued -- $0 $161.8M $0 $0 $25.00M $108K $609K $60K
Financing Cash Flow $878.2M $214.5M $163.5M $163.6M $37.98M $232.2M $108K $70.35M -$729K
Net Change in Cash $214.3M $44.94M -$87.91M -$79.80M -$22.51M $204.8M -$18.25M $27.33M -$12.98M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$111.4M -$96.41M -$97.35M -$102.5M -$80.93M -$73.53M -$71.99M -$67.93M
Depreciation & Amortization $572K $741K $626K $664K $641K $655K $640K $675K
Stock-Based Compensation $16.87M $17.11M $16.91M $15.75M $10.60M $9.72M $10.01M $9.98M
Change in Payables -$1.55M -$6.26M $4.24M -$6.53M -$596K $2.47M $2.14M -$3.05M
Operating Cash Flow -$80.79M -$77.27M -$86.88M -$79.11M -$64.29M -$54.54M -$66.51M -$60.58M
Capital Expenditure -$108K -$370K -$449K -$811K -$65K -$131K -$547K -$75K
Free Cash Flow -$80.89M -$77.64M -$87.33M -$79.92M -$64.35M -$54.67M -$67.06M -$60.65M
Purchases of Investments -$74.07M -$82.81M -$133.8M -$395.2M -$224.1M -$67.88M $0 -$12.72M
Investing Cash Flow $37.31M $14.28M -$36.46M -$322.8M -$155.0M $8.91M $69.38M $61.67M
Financing Cash Flow $79.76M $2.96M $52.54M $588.7M $217.4M $47.23M $24.97M $26K
Net Change in Cash $36.29M -$60.04M -$70.80M $186.8M -$1.97M $1.59M $27.84M $1.12M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Operating Margin -- -- -- -- -- -1044.3% -143.0% -369.9% -312.8%
Net Profit Margin -- -- -- -- -- -950.4% -141.5% -354.8% -304.9%
Return on Equity (ROE) -51.7% -99.8% -74.6% -54.8% -33.7% -31.9% -100.2% -57.3% --
Return on Assets (ROA) -35.1% -78.0% -61.4% -46.6% -31.1% -29.8% -64.4% -40.2% -51.9%
Current Ratio 14.23x 5.32x 7.09x 9.87x 13.04x 18.70x 3.06x 3.25x 3.79x
Quick Ratio 14.08x 5.15x 6.96x 9.66x 12.86x 18.50x 2.98x 2.30x 3.73x
Debt to Equity 0.38x 0.07x 0.07x 0.08x 0.01x 0.02x 0.19x -- --
Revenue Growth (YoY) -- -- -- -- -- -65.0% +131.1% +16.4% --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Return on Equity (ROE) -79.0% -70.8% -58.3% -51.7% -97.3% -183.2% -123.1% -99.8%
Return on Assets (ROA) -49.0% -45.2% -39.2% -35.1% -69.1% -103.4% -95.0% -78.0%
Current Ratio 10.99x 13.57x 15.14x 14.23x 6.38x 4.19x 5.13x 5.32x
Quick Ratio 10.82x 13.36x 14.94x 14.08x 6.28x 4.07x 4.98x 5.15x
Debt to Equity 0.47x 0.46x 0.39x 0.38x 0.20x 0.39x 0.08x 0.07x
Source: SEC EDGAR CompanyFacts (CIK 0001622229) · from March 31, 2017 Data through September 30, 2026 · synced Nov 20, 2026, 05:15 UTC · Open in terminal